BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shirakawa K, Sano M. Osteopontin in Cardiovascular Diseases. Biomolecules 2021;11:1047. [PMID: 34356671 DOI: 10.3390/biom11071047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Scicchitano P, Cameli M. Advances in Molecular Biomarkers in Cardiology. Biomolecules 2022;12:1530. [PMID: 36291738 DOI: 10.3390/biom12101530] [Reference Citation Analysis]
2 Rotem I, Konfino T, Caller T, Schary Y, Shaihov-Teper O, Palevski D, Lewis N, Lendengolts D, Naftali-Shani N, Leor J. Osteopontin promotes infarct repair. Basic Res Cardiol 2022;117:51. [PMID: 36239866 DOI: 10.1007/s00395-022-00957-0] [Reference Citation Analysis]
3 Imig JD. Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKD. Kidney360 2022;3:1477-1479. [DOI: 10.34067/kid.0004292022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kadoglou NPE, Kapetanios D, Korakas E, Valsami G, Tentolouris N, Papanas N, Lambadiari V, Karkos C. Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease. Cardiovasc Diabetol 2022;21:171. [PMID: 36050687 DOI: 10.1186/s12933-022-01605-6] [Reference Citation Analysis]
5 Sellmer A, Henriksen TB, Palmfeldt J, Bech BH, Astono J, Bennike TB, Hjortdal VE. The Patent Ductus Arteriosus in Extremely Preterm Neonates Is More than a Hemodynamic Challenge: New Molecular Insights. Biomolecules 2022;12:1179. [DOI: 10.3390/biom12091179] [Reference Citation Analysis]
6 Chen F, Wang Y. Osteopontin promotes microglia activation and aggravates neuromyelitis optica via interferon-gamma/nuclear factor kappa B/interleukin-12 signaling. Mol Cell Toxicol 2022. [DOI: 10.1007/s13273-022-00265-7] [Reference Citation Analysis]
7 Kosowski M, Basiak M, Hachuła M, Okopień B. Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque. Medicina 2022;58:969. [DOI: 10.3390/medicina58070969] [Reference Citation Analysis]
8 Cheng Y, Li Y, Scherer N, Grundner-culemann F, Lehtimäki T, Mishra BH, Raitakari OT, Nauck M, Eckardt K, Sekula P, Schultheiss UT, on behalf of the GCKD investigators. Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study. PLoS Genet 2022;18:e1010139. [DOI: 10.1371/journal.pgen.1010139] [Reference Citation Analysis]
9 Pérez-Hernández N, Posadas-Sánchez R, Vargas-Alarcón G, Hernández-Germán LP, Borgonio-Cuadra VM, Rodríguez-Pérez JM. Osteopontin Gene Polymorphisms Are Associated with Cardiovascular Risk Factors in Patients with Premature Coronary Artery Disease. Biomedicines 2021;9:1600. [PMID: 34829826 DOI: 10.3390/biomedicines9111600] [Reference Citation Analysis]
10 Mohamed R, Tawfeek E, Abdel-salam M, Ghoraba NM, Maghraby H. The Relationship between Circulating Levels of Osteopontin with Carotid Intima-Media Thickness in Children on Regular Hemodialysis. OJNeph 2021;11:467-476. [DOI: 10.4236/ojneph.2021.114039] [Reference Citation Analysis]